Therapeutic Effect of Losartan, an Angiotensin II Type 1 Receptor Antagonist, on CCl₄-Induced Skeletal Muscle Injury

By Hwang Ok-Kyung   Park Jin-Kyu   Lee Eun-Joo   Lee Eun-Mi   Kim Ah-Young   Jeong Kyu-Shik  

International Journal of Molecular Sciences, Vol. 17, Iss. 2, 2016-02 ,pp. : 227-227

MDPI

Access to resources Recommend Favorite

Soluble Receptor for Advanced Glycation End-Product (sRAGE)/Pentosidine Ratio: A Potential Risk Factor Determinant for Type 2 Diabetic Retinopathy

By Ng Zhi Xiang   Chua Kek Heng   Iqbal Tajunisah   Kuppusamy Umah Rani  

International Journal of Molecular Sciences, Vol. 14, Iss. 4, 2013-04 ,pp. : 7480-7491

MDPI

Access to resources Recommend Favorite

Specific siRNA Targeting the Receptor for Advanced Glycation End Products Inhibits Experimental Hepatic Fibrosis in Rats

By Xia Jin-Rong   Liu Nai-Feng   Zhu Nai-Xun  

International Journal of Molecular Sciences, Vol. 9, Iss. 4, 2008-04 ,pp. : 638-661

MDPI

Access to resources Recommend Favorite

N-Acetyl Cysteine Attenuated the Deleterious Effects of Advanced Glycation End-Products on the Kidney of Non-Diabetic Rats

By  

Cellular Physiology and Biochemistry, Vol. 40, Iss. 3-4, 2016-11 ,pp. : 608-620

Karger

Access to resources Recommend Favorite

Advanced Glycation End Product (AGE)-AGE Receptor (RAGE) System Upregulated Connexin43 Expression in Rat Cardiomyocytes via PKC and Erk MAPK Pathways

By Yu Lu   Zhao Yanbo   Xu Shengjie   Ding Fang   Jin Chongying   Fu Guosheng   Weng Shaoxiang  

International Journal of Molecular Sciences, Vol. 14, Iss. 2, 2013-01 ,pp. : 2242-2257

MDPI

Access to resources Recommend Favorite